Your browser doesn't support javascript.
loading
Discovery of novel dual PPARα/δ agonists based on benzimidazole scaffold for the treatment of non-alcoholic fatty liver disease.
Li, Zheng; Xu, Yawen; Cai, Zongyu; Wang, Xuekun; Ren, Qiang; Zhou, Zongtao; Xie, Rongrong.
Affiliation
  • Li Z; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China; Key Laboratory of New Drug Discovery and Evaluation of Ordinary Universities of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou 510006, PR China. Electronic address: li.zheng.sky@163.com.
  • Xu Y; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
  • Cai Z; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
  • Wang X; College of Pharmacy, Liaocheng University, Liaocheng 252059, PR China.
  • Ren Q; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
  • Zhou Z; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
  • Xie R; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China. Electronic address: happyyunyun_1985@126.com.
Bioorg Chem ; 99: 103803, 2020 06.
Article in En | MEDLINE | ID: mdl-32251945
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / PPAR alpha / PPAR gamma / Drug Discovery / Fatty Liver / Non-alcoholic Fatty Liver Disease Limits: Animals / Humans / Male Language: En Journal: Bioorg Chem Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / PPAR alpha / PPAR gamma / Drug Discovery / Fatty Liver / Non-alcoholic Fatty Liver Disease Limits: Animals / Humans / Male Language: En Journal: Bioorg Chem Year: 2020 Document type: Article Country of publication: